Chapter 29: Amino Acid Carbon Skeleton Metabolism

The focus is on the diverse fates of the remaining hydrocarbon skeletons, which are systematically converted into amphibolic intermediates. These intermediates serve as vital precursors for the biosynthesis of carbohydrates (glycogenic) or lipids (ketogenic), or they are oxidized for energy within the citric acid cycle. While most amino acid catabolism begins with transamination, specific exceptions like proline, hydroxyproline, threonine, and lysine utilize alternative initial reactions. The text details how specific amino acids converge onto major metabolic hubs; for instance, asparagine and aspartate form oxaloacetate, while glutamine, glutamate, arginine, and proline are processed into alpha-ketoglutarate. The degradation of branched-chain amino acids—leucine, isoleucine, and valine—is particularly notable for its chemical similarity to fatty acid oxidation, involving multi-step oxidative decarboxylation catalyzed by complex enzyme systems. A significant portion of the chapter is dedicated to the clinical implications of these pathways, specifically "inborn errors of metabolism." These rare but severe genetic disorders, such as Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), and Alkaptonuria, arise from mutations that result in nonfunctional enzymes. Such defects lead to the accumulation of toxic catabolites, often causing irreversible neurological damage or early mortality if not identified through neonatal screening. Historical milestones, such as Sir Archibald Garrod’s work on alkaptonuria and the detection of metabolic signatures in Egyptian mummies, highlight the enduring nature of these biochemical challenges. Modern diagnostic techniques, including tandem mass spectrometry and prenatal amniocentesis, are emphasized as essential tools for the early detection and management of these conditions, which typically involve strictly controlled dietary interventions to prevent metabolic crisis.